1. How Do Pharmaceutical Companies Model Survival of Cancer Patients? A Review of NICE Single Technology Appraisals in 2017. (2019) Authors: Gallacher, Daniel; Auguste, Peter; Connock, Martin Journal: International journal of technology assessment in health care Issue: Volume 35:Number 2(2019) Page Start: 160 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Test accuracy of drug and antibody assays for predicting response to antitumour necrosis factor treatment in Crohn's disease: a systematic review and meta-analysis. Issue 6 (2nd July 2017) Authors: Freeman, Karoline; Taylor-Phillips, Sian; Connock, Martin; Court, Rachel; Tsertsvadze, Alexander; Shyangdan, Deepson; Auguste, Peter; Mistry, Hema; Arasaradnam, Ramesh; Sutcliffe, Paul; Clarke, Aileen Journal: BMJ open Issue: Volume 7:Issue 6(2017) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A systematic review of economic models used to assess the cost-effectiveness of strategies for identifying latent tuberculosis in high-risk groups. (July 2016) Authors: Auguste, Peter; Tsertsvadze, Alexander; Court, Rachel; Pink, Joshua Journal: Tuberculosis Issue: Volume 99(2016) Page Start: 81 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. OP135 Impact Of Updated Trial Data On The Cost-effectiveness Of Health Technologies: A Case Study On Percutaneous Mitral Repair. (December 2021) Authors: Armoiry, Xavier; Auguste, Peter; Obadia, Jean-François; Grinberg, Daniel; Connock, Martin Journal: International journal of technology assessment in health care Issue: Volume 37(2021)Supplement 1 Page Start: 3 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. A systematic review of economic models used to assess the cost-effectiveness of strategies for identifying latent tuberculosis in high-risk groups. (July 2016) Authors: Auguste, Peter; Tsertsvadze, Alexander; Court, Rachel; Pink, Joshua Journal: Tuberculosis Issue: Volume 99(2016) Page Start: 81 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Is the assumption of waning of treatment effect applied consistently across NICE technology appraisals? A case-study focusing on disease-modifying therapies for treatment of multiple sclerosis. (13th December 2022) Authors: Armoiry, Xavier; Wang-Steverding, Xia; Connock, Martin; Grove, Amy; Clarke, Aileen; Arun, Tarunya; Counsell, Carl; Auguste, Peter Journal: International journal of technology assessment in health care Issue: Volume 38(2022)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Will the US$5 million onasemnogene abeparvosec treatment for spinal muscular atrophy represent 'value for money' for the NHS? A rapid inquiry into suggestions that it may be cost-effective. (2nd July 2020) Authors: Connock, Martin; Andronis, Lazaros; Auguste, Peter; Dussart, Claude; Armoiry, Xavier Journal: Expert opinion on biological therapy Issue: Volume 20:Number 7(2020) Page Start: 823 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Cost-effectiveness of community health systems strengthening: quality improvement interventions at community level to realise maternal and child health gains in Kenya. Issue 3 (3rd March 2021) Authors: Kumar, Meghan Bruce; Madan, Jason J; Auguste, Peter; Taegtmeyer, Miriam; Otiso, Lilian; Ochieng, Christian B; Muturi, Nelly; Mgamb, Elizabeth; Barasa, Edwine Journal: BMJ global health Issue: Volume 6:Issue 3(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Diabetic retinopathy and the use of laser photocoagulation: is it cost-effective to treat early?. Issue 1 (25th September 2017) Authors: Mistry, Hema; Auguste, Peter; Lois, Noemi; Waugh, Norman Journal: BMJ open ophthalmology Issue: Volume 2:Issue 1(2017) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Potential impact on cost-effectiveness estimates of using immature survival data: a case study based on transcatheter edge-to-edge repair (TEER) used for patients with severe mitral regurgitation at high surgical risk. Issue 3 (14th March 2023) Authors: Connock, Martin; Auguste, Peter; Capelle, Aude; Hénaine, Anna-Maria; Obadia, Jean-François; Armoiry, Xavier Journal: BMJ open Issue: Volume 13:Issue 3(2023) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗